Beranda › Penyakit Radang Usus › Texas
Uji klinis Penyakit Radang Usus di Texas
16 studi untuk Penyakit Radang Usus mencari peserta di lokasi di Texas.
Kota di Texas
- Houston8 studi
- Tyler5 studi
- Round Rock5 studi
- Garland4 studi
- Fort Worth4 studi
- Lewisville4 studi
- San Antonio3 studi
- League City3 studi
- Lubbock3 studi
Teks studi resmi (Bahasa Inggris)
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
- Inquest Clinical Research, Baytown
- DHR Health Gastroenterology - Edinburg, Edinburg
- Baylor College of Medicine, Houston
- dan 3 lainnya
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT06598943Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
- Xencor Investigative Site, Cedar Park
- Xencor Investigative Site, Denton
- Xencor Investigative Site, Garland
- dan 8 lainnya
Menerima pesertaFase 1/2Sukarelawan sehat diterima
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT06619990A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Site 013, Cedar Park
- Site 005, Garland
- Site 002, San Antonio
- dan 2 lainnya
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT07012395A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
- Site US-024, Garland
- Site US-009, Georgetown
- Site US-030, Houston
- dan 4 lainnya
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT07845487A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
- Cook Childrens Medical Center, Fort Worth
Menerima pesertaFase 3
Usia 2 hingga 17 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT05923073Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
- UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
- dan 2 lainnya
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT03816345Study of DISC-0974-201 in Participants With IBD and Anemia
- One of a Kind Clinical Research Center, LLC, Kingwood
- Siena Research Network, Sugar Land
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT07368972A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
- GI Alliance - Cedar Park, Cedar Park
- North Texas Gastroenterology, Denton
- The University of Texas Health Science Center at Houston, Houston
- dan 3 lainnya
Menerima pesertaFase 2
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT06226883A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- Cook Children's Medical Center, Fort Worth
Menerima pesertaFase 3
Usia 2 hingga 19 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT04844606A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
- Cook Children's Medical Center, Fort Worth
Menerima pesertaFase 3
Usia 2 hingga 17 · Semua jenis kelamin · Diperbarui 24 Agu 2026 · NCT05509777BOOM-IBD2 Pivotal Clinical Trial
- Amarillo Premier Research (Objective Health), Amarillo
- Digestive Research of Central Texas (Objective Health), Waco
Menerima peserta
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 6 Agu 2026 · NCT06571669HB-adMSCs for the Treatment of Crohn's Disease
- Hope Biosciences Research Foundation, Sugar Land
Menerima pesertaFase 2
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 6 Agu 2026 · NCT07077746Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
- M D Anderson Cancer Center, Houston
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Mei 2026 · NCT04751396A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Dallas
- Mirador Therapeutics Selected Site, Garland
- Mirador Therapeutics Selected Site, Georgetown
- dan 5 lainnya
Menerima pesertaFase 2
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 12 Mar 2026 · NCT07113522Testing the Impact of Measurement-Based Care on Quality of Life and Disease Management Among Veterans With Inflammatory Bowel Disease
- Michael E. DeBakey VA Medical Center, Houston, TX, Houston
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Mar 2026 · NCT07210580Registry and Biorepository for IBD in Central Texas
- Dell Medical School, UT Austin, Austin
Menerima pesertaStudi observasional
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 18 Mei 2021 · NCT04617184Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.